Recital 6, Regulation (EU) 2017/1376

In forcesince 25 Jul 2017

In addition, the use of products containing warfarin raises concerns in relation to instances of primary and secondary poisoning, even where restrictive risk management measures are applied and therefore warfarin also satisfies the criterion to be a candidate for substitution in accordance with Article 10(1)(e) of that Regulation.